Mahalaxmi Drugs Limited - Company Profile

It is a chemicals public limited company based in Hyderabad-40, Telangana, India, established in 2000.
2000 Hyderabad-40, Telangana, India Struck Off
Last Updated:
Access Report
About Mahalaxmi Drugs Limited

Mahalaxmi Drugs Limited, a struck off public limited company, was established on 24 January 2000 in Hyderabad-40, Telangana, India. Engaging in other chemical product within the chemicals sector, it holds CIN: U24231TG2000PLC033342. Registered under ROC Roc Hyderabad. it is unlisted. It has an authorized capital of ₹1.00 M and a paid-up capital of ₹0.50 M.

Its leadership includes Chandrakant Vadilal Shah (Director), Chittal Chandrakant Shah (Director), Shreepal Chandrakant Shah (Director). Its latest AGM occurred on 10 August 2010, with the balance sheet filed on 31 March 2010. It is based at 301, Indralok, Road No.D1,Opp;Taj Residency, Hotel Banjarahlls,, Hyderabad-40, Telangana, 500034.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U24231TG2000PLC033342

  • Registration Number

    033342

  • Incorporation Date

    24 January 2000

  • Authorized Capital

    ₹1.00 M

  • Paid-Up Capital

    ₹0.50 M

  • ROC Code

    Roc Hyderabad

  • Listing Status

    Unlisted

  • Company Status

    Struck Off

Key Metrics
  • Authorised Capital ₹ 1.00 M
  • Paid Up Capital ₹ 0.50 M
  • Company Age 26 Year, 1 Month
  • Last Filing with ROC 31 Mar 2010
Company report

Mahalaxmi Drugs Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Mahalaxmi Drugs Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at Mahalaxmi Drugs Limited?
Current Directors
Name Designation Appointment Date Status
Chandrakant Vadilal Shah Director 24 Jan 2000 Current
Chittal Chandrakant Shah Director 24 Jan 2000 Current
Shreepal Chandrakant Shah Director 07 Jun 2005 Current

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Mahalaxmi Drugs.

Enhance accessibility to Mahalaxmi Drugs's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.

Mahalaxmi Drugs revenue growth over time
Mahalaxmi Drugs profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
*******
*******
*******
*******
*******
Revenue from Operations
*******
*******
*******
*******
*******
*******
Total Assets
*******
*******
*******
*******
*******
*******
Profit or Loss
*******
*******
*******
*******
*******
*******
Net Worth
*******
*******
*******
*******
*******
*******
EBITDA
*******
*******
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Mahalaxmi Drugs?

Unlock access to Mahalaxmi Drugs's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

How Many Employees Work at Mahalaxmi Drugs?

Unlock and access historical data on people associated with Mahalaxmi Drugs, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Mahalaxmi Drugs, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Mahalaxmi Drugs's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Mahalaxmi Drugs
Recent Activity within the Organization
  • Annual General Meeting

    Mahalaxmi Drugs Limited last Annual general meeting of members was held on 10 Aug 2010 as per latest MCA records. was recorded as a recent event.

  • Balance Sheet

    The activity Mahalaxmi Drugs Limited has filed its annual Financial statements for the year ended 31 Mar 2010 with Roc Hyderabad. was completed.

  • Director Appointment

    Shreepal Chandrakant Shah was appointed as a Director was appointed as a Director on 07 Jun 2005 & has been associated with this company since 20 years 8 months . was recorded as a recent event.

  • Director Appointment

    Progress on Chandrakant Vadilal Shah was appointed as a Director was appointed as a Director on 24 Jan 2000 & has been associated with this company since 26 years 1 month . was documented.

  • Director Appointment

    Progress on Chittal Chandrakant Shah was appointed as a Director was appointed as a Director on 24 Jan 2000 & has been associated with this company since 26 years 1 month . was documented.

  • Company Incorporation

    Mahalaxmi Drugs Limited was registered on 24 Jan 2000 with Roc Hyderabad & aged 26 years 1 month as per MCA records. was recorded as a recent event.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Mahalaxmi Drugs Limited?

The CIN of Mahalaxmi Drugs Limited is U24231TG2000PLC033342.

Where is Mahalaxmi Drugs Limited headquartered?

Mahalaxmi Drugs Limited is headquartered at 301, Indralok, Road No.D1,Opp;Taj Residency, Hotel Banjarahlls,, Hyderabad-40, Telangana, 500034.

When was Mahalaxmi Drugs Limited incorporated?

Mahalaxmi Drugs Limited was incorporated on 24 January 2000.

Who are the current directors of Mahalaxmi Drugs Limited?

The current directors of Mahalaxmi Drugs Limited are

What is the primary industry of Mahalaxmi Drugs Limited?

The primary industry of Mahalaxmi Drugs Limited is Chemicals.

Is Mahalaxmi Drugs Limited a listed company?

Mahalaxmi Drugs Limited is unlisted.

What is the capital structure of Mahalaxmi Drugs Limited?

The authorized capital of Mahalaxmi Drugs Limited is ₹1.00 M, and the paid-up capital is ₹0.50 M.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available